Back to STATE STREET CORP STATE STREET CORP

CRVSCRVS
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in CORVUS PHARMACEUTICALS INC

STATE STREET CORP holds 4.5M shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $66.8M as of 2026-Q2. The position was increased (+25.5% shares). CRVS represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$66.8M

Current Shares

4.5M

Total Value Change

+$66.6M

Total Shares Change

+4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.5M
+25.5%
$66.8M0.0%$14.94
36
2026-Q1
Increased
3.6M
+27.9%
$52.2M0.0%$17.53
37
2025-Q4
Increased
2.8M
+177.1%
$21.5M0.0%$7.49
46
2025-Q3
Increased
1M
+51.4%
$7.4M0.0%$7.28
38
2025-Q2
Increased
664,768
+189.0%
$2.7M0.0%$3.89
42
2025-Q1
Increased
230,038
+11.9%
$731,5210.0%$3.38
19
2024-Q4
Increased
205,538
+15.3%
$1.1M0.0%$5.25
20
2024-Q3
Increased
178,246
+48.2%
$941,1390.0%$5.15
23
2024-Q2
Unchanged
120,303
0.0%
$218,9510.0%$1.82
0
2024-Q1
Decreased
120,303
-13.1%
$214,1390.0%$1.78
0
2023-Q4
New
138,403
-
$243,5890.0%$1.76
35

Other major holders of CRVS: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used